GP-531 tartrate | CAS# 911205-04-4 | Biochemical

MedKoo Cat#: 575950 | Name: GP-531 tartrate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

GP-531 tartrate is an adenosine-regulating agent with cardioprotective effects.

Chemical Structure

GP-531 tartrate

CAS#911205-04-4

Theoretical Analysis

MedKoo Cat#: 575950

Name: GP-531 tartrate

CAS#: 911205-04-4

Chemical Formula: C20H27N5O10

Exact Mass: 497.1758

Molecular Weight: 497.46

Elemental Analysis: C, 48.29; H, 5.47; N, 14.08; O, 32.16

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

GP-531 tartrate; GP 531 tartrate; GP531 tartrate

IUPAC/Chemical Name

1H-Imidazole-4-carboxamide, 5-amino-1-(5-deoxy-5-((phenylmethyl)amino)-beta-D-ribofuranosyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)

InChi Key

VKQWMBKJUARLCQ-REMRMEERSA-N

InChi Code

InChI=1S/C16H21N5O4.C4H6O6/c17-14-11(15(18)24)20-8-21(14)16-13(23)12(22)10(25-16)7-19-6-9-4-2-1-3-5-9;5-1(3(7)8)2(6)4(9)10/h1-5,8,10,12-13,16,19,22-23H,6-7,17H2,(H2,18,24);1-2,5-6H,(H,7,8)(H,9,10)/t10-,12-,13-,16-;1-,2-/m11/s1

SMILES Code

NC(=O)c1ncn([C@@H]2O[C@H](CNCc3ccccc3)[C@@H](O)[C@H]2O)c1N.O[C@H]([C@@H](O)C(=O)O)C(=O)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 497.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1. Hale SL, Kloner RA. Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit. J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):60-7. doi: 10.1177/1074248409357742. PMID: 20133497. 2. Kurz MA, Bullough DA, Buggé CJ, Mullane KM, Young MA. Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine. Eur J Pharmacol. 1997 Mar 19;322(2-3):211-20. doi: 10.1016/s0014-2999(97)00011-3. PMID: 9098689. 3. Chen LS, Fujitaki JM, Dixon R. A sensitive assay for the aminoimidazole-containing drug GP531 in plasma using liquid chromatography with amperometric electrochemical detection: a new class of electroactive compounds. J Pharm Biomed Anal. 1996 Aug;14(11):1535-8. doi: 10.1016/0731-7085(95)01719-4. PMID: 8877860.